Convalescent Plasma Collection and Treatment in Pediatrics and Adults

Completed · Phase 3

Conditions studied: COVID19, Coronavirus Infection, Coronavirus, Virus Diseases, RNA Virus Infections

In brief

This is a prospective study, using plasma to help fight off infections of those suffering from COVID-19 in accordance with collection guidelines for plasma and FDA IND requirements. This study included up to 240 participants potentially receiving convalescent plasma. NOTE: West Virginia does not have any entity with the required FDA registration/licensure or necessary equipment to collect convalescent plasma for transfusion. Therefore, the plasma donation portion of this study was not completed.

Key facts

Study ID

NCT04376034

Run by

West Virginia University

People needed

117

Starts

2020-04-16

Expected to finish

2021-04-21

Last updated by the study team

2026-05-29

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Plasma donation:
• Individuals that do not meet the requirement from the American Red Cross for plasma donation or equivalent
• Individuals plasma that has not passed safety screening after procurement by the American Red Cross for plasma donation or equivalent
• Plasma Recipients
• Individuals with COVID19 who are not in clinical concern for rapid progression, severe or critical condition
• Individuals who are in critical condition that are not confirmed to have COVID19
• Individuals with known Selective IgA Deficiency, that has not been found to be absent of anti-IgA antibodies

Where it is running

• WVU Medicine — Morgantown, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.